Iboga Treatment Center — Ensenada, Mexico
Iboga Treatment Center is a medically supervised ibogaine facility located in Ensenada, Baja California, approximately two hours south of San Diego. The center focuses primarily on substance use disorders, including opioid, methamphetamine, prescription drug, and alcohol addiction, while also listing PTSD, depression, trauma, and traumatic brain injury (TBI) among the conditions it addresses.
What Makes This Center Notable
- Cardiac screening protocol: The clinic explicitly references cardiac protection measures, including magnesium supplementation, as part of its pre-treatment and treatment process. Cardiac risk is a documented concern with ibogaine, making this a relevant detail to verify directly.
- Medical supervision: Treatment is described as medically supervised with comprehensive cardiac and psychological evaluation prior to admission.
- Aftercare support: The center states a minimum of 30 days of aftercare support is included, which may assist in the post-treatment transition period.
- Location: Proximity to the US–Mexico border (San Diego) makes logistics relatively accessible for North American clients.
Pricing
| Program | Duration | Price (USD) |
|---|---|---|
| Standard Program | 1 week | $7,500 |
| Extended Program | 1 month | $16,500 |
Pricing is site-confirmed. Confirm current rates and what is included directly with the clinic before making any financial commitments.
What to Research Before Committing
- Accreditation: No formal accreditation is listed for this clinic. Ask directly about staff credentials, medical licensing, and how emergencies are managed on-site.
- Cardiac screening specifics: Request details on the exact screening protocol — including whether an ECG is performed — given the known QT-prolongation risks associated with ibogaine.
- Aftercare structure: Clarify what the 30-day aftercare support consists of, whether it is remote or in-person, and who provides it.
- Contraindications: Discuss your full medical and psychiatric history with the clinic and an independent physician before proceeding.
- Legal context: Ibogaine is not approved for therapeutic use in the United States. Understand the legal and logistical implications of traveling to Mexico for treatment.
Important: Ibogaine carries documented cardiac risks and is not approved by the FDA. Independent medical consultation before enrollment is strongly advised.